Clinical drugs research in children: New international guidelines;Klinisch geneesmiddelenonderzoek bij kinderen: Nieuwe internationale richtlijnen

Nederlands Tijdschrift voor Geneeskunde

Volumn 142, Issue 1, 1998, Pages 6-9

  Ruys Dudok Van Heel, I ^a   Cohen, A F ^a   Wit, J M ^b   Van Der Heijden, A J ^c   Van Den Anker, J N ^d   Van Meurs, A H J ^c  

^a CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c JULIANA CHILDREN S HOSPITAL   (Netherlands)

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD DEVELOPMENT; CLINICAL RESEARCH; DRUG RESEARCH; EUROPEAN UNION; GOOD CLINICAL PRACTICE; NOTE; PRACTICE GUIDELINE;

CHILD; CLINICAL TRIALS; DRUG THERAPY; ETHICS, MEDICAL; EUROPE; HUMANS; NETHERLANDS; PHARMACOKINETICS;

EID: 0002197337     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (16)

1. Ziekenfondsraad GeneesmiddelenInformatieProject (GIP) GIPeilingen 1995, kengetallen farmaceutische hulp. Amstelveen: Ziekenfondsraad, 1996.
2. Besunder JB, Reed MD, Blumer JL. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (part I). Clin Pharmacokinet 1988;14: 189-216.
3. Besunder JB, Reed MD, Blumer JL. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (part II). Clin Pharmacokinet 1988;14: 261-86.
4. Anker JN van den. Groot R de Clinical pharmacokinetics of anti-bacterial agents in pre-term infants. Rev Med Microbiol 1996;7-179-94.
5. Butler DR, Kuhn RJ, Chandler MHH. Pharmacokinetics of anti-infective agents in paediatric patients. Clin Pharmacokinet 1994; 26:374-95.
6. Rademaker CMA, Anker JN van den, Roord JJ. Farmacotherapie in de kindergeneeskunde. Pharm Weekbl 1997;132:429-34.
7. The Royal College of Paediatrics and Child Health. Licensing medicines for children. Londen: The Royal College of Paediatrics and Child Health, 1996.
8. House of Commons Health Committee. The specific health needs of children and young people. Vol 1, Londen: The Stationary Office, 1997.
9. Warden J. Loophole exposed in testing of child medicines. BMJ 1997;314:698.
10. UK alarm over children's medicines. Scrip, World Pharmaceutical News 1997;2213:4.
11. Kauffman RE. Status of drug approval processes and regulation of medications for children. Curr Opin Pediatr 1995;7:195-8.
12. EEC Note for guidance: good clinical practice for trials on medicinal products in the European Community III/3976/88-EN Londen: ICH, 1991.
13. Commissie medische experimenten met wilsonbekwamen. Medisch wetenschappelijk onderzoek met wilsonbekwamen. Advies inzake regeling van medisch wetenschappelijk onderzoek met minderjarigen en meerderjarige wilsonbekwamen aan de minister van Volksgezondheid, Welzijn en Sport (VWS) en de minister van Justitie. Rijswijk: Ministerie van VWS, 1995.
14. Committee for Proprietary Medicinal Products. Note for guidance on good clinical practice CPMP/ICH/135/95. Londen: ICH, 1997.
15. Committee for Proprietary Medicinal Products. Note for guidance on clinical investigation of medicinal products in children. CPMP/EWP/462/95. Londen: ICH. 1997.
16. Taddio A, Stevens B, Craig K, Rastogi P, Ben-David S, Shennan A, et al Efficacy and safety of lidocaine-prilocaine cream for pain during circumcision. N Engl J Med 1997;336:1197-201.